Can leaky splicing and evasion of premature termination codon surveillance contribute to the phenotypic variability in Alkuraya-Kucinskas syndrome?


Journal

European journal of medical genetics
ISSN: 1878-0849
Titre abrégé: Eur J Med Genet
Pays: Netherlands
ID NLM: 101247089

Informations de publication

Date de publication:
Mar 2022
Historique:
received: 14 06 2021
revised: 28 12 2021
accepted: 15 01 2022
pubmed: 23 1 2022
medline: 5 4 2022
entrez: 22 1 2022
Statut: ppublish

Résumé

Disease-associated variants in KIAA1109 associate with autosomal recessive Alkuraya-Kucinskas syndrome, which is typified by cerebral parenchymal underdevelopment, clubfeet, and arthrogryposis. Biallelic truncating variants occur with severe disease resulting in miscarriage or early neonatal death, whereas biallelic missense variants can occur with a milder phenotype of global developmental delay and intracranial malformation. This suggests that hypomorphic alleles in KIAA1109 give rise to a milder phenotype than do amorphic alleles. We describe a consanguineous family with pseudodominant segregation of a homozygous noncanonical splice donor variant (NM_015312.2:c.[13438+3A>G];[13438+3A>G]) in mother and daughter. In peripheral blood, sequencing of cDNA detected skipping of exon 76 (NM_015312.3:c.13281_13438del) and, by qRT-PCR quantification, occurred in 82-95% of peripheral blood KIAA1109 mRNA. Although the deletion of exon 76 is predicted to encode p.(Trp4428Serfs*4), 46-83% of KIAA1109 mRNA in peripheral blood evaded nonsense mediated mRNA decay as measured by qRT-PCR. These observations expand understanding of the genotype-phenotype association in KIAA1109-related disease and suggest hypotheses for milder presentations of Alkuraya-Kucinskas syndrome.

Identifiants

pubmed: 35063693
pii: S1769-7212(22)00008-8
doi: 10.1016/j.ejmg.2022.104427
pii:
doi:

Substances chimiques

Codon, Nonsense 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104427

Informations de copyright

Copyright © 2022. Published by Elsevier Masson SAS.

Auteurs

Hui-Lin Chin (HL)

Department of Medical Genetics and Provincial Medical Genetics Program, University of British Columbia and Women's Hospital of British Columbia, Vancouver, BC, Canada; Khoo Teck Puat-National University Children's Medical Institute, National University Hospital, Singapore. Electronic address: hui-lin_chin@nuhs.edu.sg.

Susan Lin (S)

The Rare Disease Discovery Hub, BC Children's Hospital Research Institute, University of British Columbia and BC Children's Hospital, Vancouver, BC, Canada.

Joshua Dalmann (J)

The Rare Disease Discovery Hub, BC Children's Hospital Research Institute, University of British Columbia and BC Children's Hospital, Vancouver, BC, Canada.

Bhavi Modi (B)

The Rare Disease Discovery Hub, BC Children's Hospital Research Institute, University of British Columbia and BC Children's Hospital, Vancouver, BC, Canada.

Emily Alderman (E)

Department of Medical Genetics and Provincial Medical Genetics Program, University of British Columbia and Women's Hospital of British Columbia, Vancouver, BC, Canada.

Areesha Salman (A)

The Rare Disease Discovery Hub, BC Children's Hospital Research Institute, University of British Columbia and BC Children's Hospital, Vancouver, BC, Canada.

Kate L Del Bel (KL)

The Rare Disease Discovery Hub, BC Children's Hospital Research Institute, University of British Columbia and BC Children's Hospital, Vancouver, BC, Canada.

Anna Lehman (A)

Department of Medical Genetics and Provincial Medical Genetics Program, University of British Columbia and Women's Hospital of British Columbia, Vancouver, BC, Canada; The Rare Disease Discovery Hub, BC Children's Hospital Research Institute, University of British Columbia and BC Children's Hospital, Vancouver, BC, Canada.

Stuart E Turvey (SE)

The Rare Disease Discovery Hub, BC Children's Hospital Research Institute, University of British Columbia and BC Children's Hospital, Vancouver, BC, Canada.

Cornelius F Boerkoel (CF)

Department of Medical Genetics and Provincial Medical Genetics Program, University of British Columbia and Women's Hospital of British Columbia, Vancouver, BC, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH